申请人:NOVA SOUTHEASTERN UNIVERSITY
公开号:US20160213628A1
公开(公告)日:2016-07-28
A therapeutic dosage form includes a pharmaceutically active ingredient, a crosslinked polyacid, and a linear polyacids. The crosslinked polyacid is insoluble in water, and the linear polyacid is soluble in water. The linear polyacid possesses sufficient binding sites to form a stable complex with the pharmaceutically active ingredient. The ingredients are formed into a tablet or capsule, either admixed, in layers, or separated by a coating. Abuse is deterred in that crushing causes the active ingredient to be bound and not abusable, and placing the dosage in solution causes a strong complex to be formed between the polyacid and the active ingredient, including a solution with ethanol. Other therapeutic dosage forms for reducing the incidence of tampering and abuse of pharmaceutical products and alcohol, and specifically preventing the isolation and concentration of drug constituents for misuse, and preventing excessive intake are also disclosed.
一种治疗剂型包括药物活性成分、交联聚酸和线性聚酸。交联聚酸在水中不溶,而线性聚酸在水中溶解。线性聚酸具有足够的结合位点,能够与药物活性成分形成稳定的复合物。这些成分可以形成片剂或胶囊,可以混合、分层或通过涂层分离。防止滥用的方法是,压碎会使活性成分被结合而无法滥用,将剂量溶解在溶液中会使聚酸和活性成分之间形成强大的复合物,包括乙醇溶液。还公开了其他用于减少医药产品和酒精的篡改和滥用的治疗剂型,特别是防止药物成分被隔离和浓缩以进行滥用,并防止过量摄入。